SOX9 and cancer: Several previous studies have shown that the increased expression of SOX9 in human tumor tissue may lead to a decrease in epithelial differentiation of cancer cells and the development of tumor-associated epithelial–mesenchymal transition (EMT) [29,30,31,32,33].